Please provide your email address to receive an email when new articles are posted on . Testing correctly identified 79% of patients with GI cancer as positive. Nearly all (96%) of healthy controls ...

In the rapidly expanding landscape of molecular diagnostics, the focus is shifting from top to bottom, with a redirection from post-pandemic respiratory testing to developments in gastrointestinal (GI ...

Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.

Med DataLink Gastroenterology, a medical data management and remote intraoperative monitoring software provider, has expanded its GI test analysis service. Med DataLink offers healthcare providers the ...